International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

S. Miyakis, M. D. Lockshin, T. Atsumi, D. W. Branch, R. L. Brey, R. Cervera, R. H W M Derkesen, P. G. De Groot, T. Koike, P. L. Meroni, G. Reber, Y. Shoenfeld, A. Tincani, P. G. Vlachoyiannopoulos, S. A. Krilis

Research output: Contribution to journalArticlepeer-review

Abstract

New clinical, laboratory and experimental insights, since the 1999 publication of the Sapporo preliminary classification criteria for antiphospholipid syndrome (APS), had been addressed at a workshop in Sydney, Australia, before the Eleventh International Congress on antiphospholipid antibodies. In this document, we appraise the existing evidence on clinical and laboratory features of APS addressed during the forum. Based on this, we propose amendments to the Sapporo criteria. We also provide definitions on features of APS that were not included in the updated criteria.

Original languageEnglish
Pages (from-to)295-306
Number of pages12
JournalJournal of Thrombosis and Haemostasis
Volume4
Issue number2
DOIs
Publication statusPublished - Feb 2006

Keywords

  • β glycoprotein-I
  • Anticardiolipin
  • Antiphospolipid syndrome
  • Classification criteria
  • Lupus anticoagulant
  • Thrombosis

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)'. Together they form a unique fingerprint.

Cite this